CVS Health CorporationCVSNYSE
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+27.7%
5Y CAGR+31.3%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+27.7%/yr
vs -10.5%/yr prior
5Y CAGR
+31.3%/yr
Recent deceleration
Acceleration
+38.2pp
Accelerating
Percentile
P90
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.03% |
| Q3 2025 | -5.95% |
| Q2 2025 | 0.17% |
| Q1 2025 | 1.66% |
| Q4 2024 | 0.83% |
| Q3 2024 | -0.24% |
| Q2 2024 | 1.62% |
| Q1 2024 | -1.09% |
| Q4 2023 | 2.77% |
| Q3 2023 | 1.75% |
| Q2 2023 | 1.99% |
| Q1 2023 | 1.84% |
| Q4 2022 | 1.45% |
| Q3 2022 | -6.10% |
| Q2 2022 | 1.76% |
| Q1 2022 | -0.90% |
| Q4 2021 | 0.95% |
| Q3 2021 | 1.28% |
| Q2 2021 | 2.90% |
| Q1 2021 | 1.94% |
| Q4 2020 | 0.78% |
| Q3 2020 | 1.03% |
| Q2 2020 | 4.16% |
| Q1 2020 | 1.80% |
| Q4 2019 | 1.89% |
| Q3 2019 | 2.09% |
| Q2 2019 | 2.42% |
| Q1 2019 | -11.90% |
| Q4 2018 | 46.15% |
| Q3 2018 | 2.54% |
| Q2 2018 | -8.02% |
| Q1 2018 | 2.40% |
| Q4 2017 | 8.32% |
| Q3 2017 | 2.41% |
| Q2 2017 | 1.99% |
| Q1 2017 | -5.09% |
| Q4 2016 | 2.83% |
| Q3 2016 | 3.61% |
| Q2 2016 | -1.53% |
| Q1 2016 | -1.82% |